Next-generation AAV vectors for clinical use: an ever-accelerating race.

about

From Virus to vector to medicine: Foreword by guest editors.Emerging Issues in AAV-Mediated In Vivo Gene Therapy.

P2860

Q45326914-CFE5D12D-BEAA-4984-BC0D-2A5CB346078E Q47554736-DC6C2AAE-64AC-4792-923F-6917243DC54E

P2860

Next-generation AAV vectors for clinical use: an ever-accelerating race.

Item

http://www.wikidata.org/entity/Q40100060

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Next-generation AAV vectors for clinical use: an ever-accelerating race.

@en

type

Item

label

Next-generation AAV vectors for clinical use: an ever-accelerating race.

@en

prefLabel

Next-generation AAV vectors for clinical use: an ever-accelerating race.

@en

P1476

Next-generation AAV vectors for clinical use: an ever-accelerating race.

@en

P2093

Jonas Weinmann

http://www.w3.org/2001/XMLSchema#string

P2860

A viral assembly factor promotes AAV2 capsid formation in the nucleolus

E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV Evolution

ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES

Cochlear gene therapy with ancestral AAV in adult mice: complete transduction of inner hair cells without cochlear dysfunction.

AAV2 gene therapy readministration in three adults with congenital blindness.

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.

Directed evolution of adeno-associated virus yields enhanced gene delivery vectors.

Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism.

In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.

Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles.

P2888

s11262-017-1502-7

P304

707-713

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11262-017-1502-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dirk Grimm

P577

2017-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090938180

http://www.w3.org/2001/XMLSchema#string

P698

28762205

http://www.w3.org/2001/XMLSchema#string

Next-generation AAV vectors for clinical use: an ever-accelerating race.

about

P2860

P2860

Next-generation AAV vectors for clinical use: an ever-accelerating race.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698